TITLE

Aspirin doubles sight disease risk in over-50s

PUB. DATE
January 2013
SOURCE
Daily Mail;1/22/2013, p17
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
TAKING aspirin can double the risk to the over-50s of contracting a disease that causes blindness, scientists warn.
ACCESSION #
84986356

 

Related Articles

  • Aspirinlink to eye disease in over-50s. Jenny Hope // Daily Mail;1/22/2013, p23 

    OLDER people taking aspirin face twice the risk of an eye disease that can cause blindness, say researchers. They have found a link between regular aspirin use and age-related macular degeneration, the most common cause of sight loss in those over 50.

  • Aspirin linked to eye disease in the over-50s. Jenny Hope // Daily Mail;1/22/2013, p27 

    OLDER people taking aspirin face twice the risk of an eye disease that can cause blindness, say researchers. They have found a link between regular aspirin use and age-related macular degeneration (AMD), the most common cause of sight loss in those over 50.

  • Ibuprofen undermines aspirin's heart effects.  // Consumer Reports on Health;Jun2005, Vol. 17 Issue 6, p10 

    Discusses the potential of ibuprofen and other over-the-counter options to counteract the ability of aspirin to resist heart attack and stroke. Role of aspirin in protecting the heart and brain; Risk factors for cardiovascular disease; Efficacy of the drugs.

  • Aspirin desensitisation cost effective for AERD.  // Reactions Weekly;3/8/2008, Issue 1192, p3 

    The article discusses information on research which provided an economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. U.S.-based researchers stated that from an economic standpoint, therapeutic aspirin desensitization should be strongly considered in patients...

  • The power pill. Drexler, Madeline // Redbook;Jan94, Vol. 182 Issue 3, p42 

    Discusses the benefits and risks of aspirin therapy. Risk factors for heart disease; Side effects of aspirin alternatives.

  • Triflusal: A Viewpoint by F. Pérez Gómez. Pérez Gómez, F. // Drugs;Jun1998, Vol. 55 Issue 6, p834 

    Comments on the efficacy of triflusal, an antiplatelet drug for heart diseases. Advantages of triflusal over aspirin; Situations in which the risk of bleeding outweighs the benefit of antiplatelet drugs.

  • New antiplatelet reduces MI incidence better than aspirin in at-risk patients. Gent, Michael // Modern Medicine;Dec97, Vol. 65 Issue 12, p41 

    Reports on the effectiveness of antiplatelet clopidogrel bisulfate in reducing the risk of myocardial infarction (MI) in patients with atherosclerotic vascular disease. Advantage over aspirin; Decrease on the risk of combined end point of ischemic stroke, MI or vascular death.

  • Check whether patients are using OTC aspirin.  // Pulse;11/11/2009, Vol. 69 Issue 36, p14 

    The article reports on the review of the periodical "Drug and Therapeutics Bulletin" on the use of over-the-counter (OTC) aspirin in Great Britain. It is stated that the review suggested the need to check high risk cardiovascular disease patients, who may be taking OTC aspirin. It notes that the...

  • THE EFFECTIVENESS OF ASPIRIN WITH REGARD TO THE AGE OF THE PERSONS SUFFERING FROM CORONARY HEART DISEASE. Al-Shammari, Ayed Mizher Habeeb; Naylor, Ian; Naylor, Robert // Canadian Journal of Applied Sciences;Jul2012, Vol. 2 Issue 3, p314 

    The present invention is related to the effectiveness of aspirin with age of person suffering from coronary heart disease. One of major cause which was observed in selected groups of patients was smoking. The age group distribution with persons who were selected for aspirin treatment who were...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics